All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe
Advertisement

Trends in Cold-Chain Packaging

April 15, 2020
By Hallie Forcinio
Article

Equipment and Processing Report

Equipment and Processing ReportEquipment and Processing Report-04-15-2020
Volume 13
Issue 4
Pages: 66–69

Consider trends for packaging that protects temperature-sensitive drugs.

Proper storage and transport temperatures for drugs, especially biologics, are essential to protect product efficacy and patient safety. “As strong growth continues across the global pharmaceutical industry, the sub-category of temperature-controlled products is surging ahead-growing at twice the rate of the industry overall,” said David Williams, president of Pelican BioThermal in a press release (1).

Joe Cintavey, product specialist at W.L. Gore, agrees, noting, “The pipeline of biologic drugs in development are becoming more temperature-sensitive, resulting in an increase in storage 
of bulk drug substance at frozen temperatures (-40 to -70 °C).” 

Rory Davidson, Business Development Manager at Almac Pharma Services, adds that labeling, packing, and distributing cell and gene therapy products often requires products to be stored and processed at ultra-low temperatures (-20 to -80 °C), with the products only being defrosted immediately prior to use. “If these products are not kept in exact conditions, they become unusable. We have seen some cases of product becoming unusable within a minute of being out of frozen conditions and so we need to be able to handle and process product at these ultra-low temperatures as quickly and efficiently as possible,” notes Davidson.

Packaging trends

In addition to the growing number of temperature-sensitive products, three trends are driving the need for temperature-controlled packaging, according to a survey by Pelican BioThermal. First, quality demands increase as more sensitive products bring logistics complexity and greatly expanded risk. Yet, while awareness of temperature-controlled requirements is high, the survey shows temperature excursions happen frequently (1). 

Second, the distribution range is expanding as products move further and through more climatic zones. More than half of survey respondents (51.8%) regularly ship products internationally, creating an increasingly complex web of local, regional, and international connections that require a broad range of transport modes (1). 

The third trend identified in the survey is the need to optimize the total cost of ownership (TCO) due to relentless competition and margin pressures. A full 70% of survey respondents agree that TCO is “important” or “very important,” while 10% consider only basic packaging costs and transport rates. This exploration of TCO is spurring interest in reusable containers, with 79% of survey respondents saying reusable containers-though more expensive than single-use containers-are worth the investment. More than one-third of respondents (37.6%) are already using reusable rental programs in their cold-chain logistics operations, and 25% are actively exploring this option (1).

As a result, validated, off-the-shelf, or customized protective packaging options continue to evolve for all temperature ranges, including controlled room temperature, refrigerated, frozen, and cryogenic. “The challenge is optimizing the design, materials, and components to minimize overall size and weight of the shipping solutions,” says Mark Barakat, general manager of Cryopak, a subsidiary of Integreon (formerly TCP Reliable). He continues, “Achieving peak performance while minimizing size, weight, and cost is typically contradictive.” Cold-chain engineering experience and tools like thermal modeling software and testing equipment play important roles in optimizing temperature-controlled packaging. 

Meeting requirements

There is also strong demand for more sustainable designs, including re-use programs to reduce the carbon footprint. Interest in temperature-controlled packaging also is being impacted by changing regulations and standards. For example, “Temperature profiles issued by ISTA [International Safe Transit Association] have changed within the past five years,” reports Barakat. 

“Regulations governing these types of highly sensitive products are growing stricter,” adds Adam Tetz, director of worldwide marketing at Pelican BioThermal. “For example,” he says, “China has become particularly strict and requires real-time tracking on all pharmaceutical shipments.” 

Many local governments want to reduce or eliminate the use of expanded polystyrene foam (EPS), a common insulating material, because it is rarely recycled. “California and New York are limiting the amount of EPS foam that can be delivered into their states,” says M. Ryan Corbin, director of marketing at Kodiakooler. These requirements are forcing makers of temperature-sensitive drugs and biologics to look for alternatives. 

In addition to insulation, temperature-controlled packaging includes single-use and reusable parcel and pallet shippers, thermal pallet covers, and phase-change materials. Sometimes, customized designs are needed, especially for products that will experience particularly hostile conditions or need to be maintained at cryogenic temperatures. Regardless of the application, optimized temperature-controlled packaging depends on the answers to three questions: Where is it being shipped? What temperature must be maintained? How long does that temperature need to be maintained? In addition, “Seasonal temperature changes can substantially affect the internal facility environment and shipping environment,” warns Joe Luke, vice president of sales and marketing for Reed-Lane, a New Jersey-based provider of contract packaging services.

Testing

To ensure packaging will perform as specified, Cryopak tests it against extreme ambient temperature profiles in its ISTA-certified lab following protocols and internal standard operating procedures. “Our shipping systems are then qualified with repetitive testing to assure consistency and performance repeatability,” explains Barakat. “The real shipment is then monitored with temperature data loggers to prove operational performance and quality assurance,” he concludes. 

To test the durability of reusable, passive thermal packaging systems, Pelican BioThermal is developing a mechanical test method. In addition to mimicking the real-world use environment, the test method also allows assessment of the impact of dynamic use on thermal performance. Tetz reports that results are promising. He says, “The test standard would give pharmaceutical manufacturers even more confidence in choosing reusable thermal packaging over single-use options to reduce costs and advance environmental initiatives.”

“Current standards assess parcel thermal packaging systems during one intense shipment from point A to point B,” explained Bill Mayer, director of research and development at Pelican BioThermal. “Throughout the development of this new test method, we addressed the challenges of exposing systems to the multi-leg and multi-mode shipping route and more of an average trip with parcel thermal packaging used multiple times” (2).

Expanding space

Figure 1. Reed-Lane recently added cold storage capabilities and a dedicated climate-controlled room for vial and ampule kitting at its packaging facility in Wayne, NJ. Image courtesy of Reed-Lane.

Reed-Lane recently added cold storage (2–8 °C) capabilities and a dedicated climate-controlled room for vial and ampule kitting at its packaging facility in Wayne, NJ (see Figure 1). Temperature and humidity sensors constantly monitor the cold storage area to document conditions and ensure there are no product-damaging temperature excursions. “Most crucially, our environmental monitoring solutions are able to provide email alerts should any specified environmental conditions be exceeded,” says Luke. He explains, “Additional sensors are deployed to provide alerts pertaining to  ... power outages, which would result in an immediate onsite power generator startup to maintain specified temperature continuity.” The dedicated room for kitting temperature-sensitive products includes space for labeling vials and ampules and assembling them with other components such as printed literature. Its location adjacent to the cold storage area minimizes intra-facility travels and exposure to temperature excursions. 

 

References

1. Pelican BioThermal, “Pelican BioThermal Reveals 2019 Biopharma Cold Chain Logistics Survey Insights Amid Surge of Temperature-Controlled Products,” Press Release, July 26, 2019. 

2. Pelican BioThermal, “Pelican BioThermal to Present Development of Laboratory Mechanical Testing Protocol for Reusable Thermal Packaging at ISTA Forum,” Press Release, May 14, 2019. 

About the author

Hallie Forcinio is packaging editor at Pharmaceutical Technology, editorhal@sbcglobal.net.

Articles in this issue

PT0420_AdobeStock_176625088_felipecaparros-1-New-1585931865599.jpg
Trends in Cold-Chain Packaging
Addressing Drug Shortages
Recent Videos
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content

Data technology background. Abstract background. Connecting dots and lines on dark background. 3D rendering. 4k. | Image Credit: © Dmitry

Emerson Unveils AI Platform for Mission-Critical Industrial Applications

Christopher Cole
May 22nd 2025
Article

Emerson’s purpose-built industrial AI solutions are meant to enhance accessibility and reliability, enabling manufacturers to maximize efficiency and performance from automation systems.


Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.


·Mirai Bio and Thermo Fisher are partnering to integrate design, delivery, and CGMP manufacturing for nucleic acid-based therapeutics.  ·The collaboration will leverage Thermo Fisher’s RNA and advanced formulations facility to support scalable development of genetic medicines.  ·Mirai’s machine intelligence platform will be combined with Thermo Fisher’s technical and manufacturing expertise to streamline drug development workflows.

Mirai Bio and Thermo Fisher Partner to Advance Genetic Medicine Manufacturing

Christopher Cole
May 21st 2025
Article

Mirai Bio and Thermo Fisher partner to integrate AI-driven design with CGMP manufacturing, aiming to streamline development of genetic medicines.


Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.


Abnormal plasma cell or b-cell in multiple myeloma emitting paraprotein 3d illustration | Image Credit: © LASZLO - stock.adobe.com

CellCentric Completes $120 Million Series C Funding Round for Multiple Myeloma Treatment Inobrodib

Patrick Lavery
May 21st 2025
Article

Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only multiple myeloma, but other specific cancers as well.


A group of antibiotic pill capsules falling. Healthcare and medical 3D illustration background | Image Credit: © James Thew - stock.adobe.com

Personalised Capsule Machine Unveiled by ACG

Christopher Cole
May 20th 2025
Article

ACG partnered with Art of You to launch the world-first Personalised Capsule Machine, enabling on-demand, customized supplement capsules based on individual health data.

Related Content

Data technology background. Abstract background. Connecting dots and lines on dark background. 3D rendering. 4k. | Image Credit: © Dmitry

Emerson Unveils AI Platform for Mission-Critical Industrial Applications

Christopher Cole
May 22nd 2025
Article

Emerson’s purpose-built industrial AI solutions are meant to enhance accessibility and reliability, enabling manufacturers to maximize efficiency and performance from automation systems.


Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.


·Mirai Bio and Thermo Fisher are partnering to integrate design, delivery, and CGMP manufacturing for nucleic acid-based therapeutics.  ·The collaboration will leverage Thermo Fisher’s RNA and advanced formulations facility to support scalable development of genetic medicines.  ·Mirai’s machine intelligence platform will be combined with Thermo Fisher’s technical and manufacturing expertise to streamline drug development workflows.

Mirai Bio and Thermo Fisher Partner to Advance Genetic Medicine Manufacturing

Christopher Cole
May 21st 2025
Article

Mirai Bio and Thermo Fisher partner to integrate AI-driven design with CGMP manufacturing, aiming to streamline development of genetic medicines.


Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.


Abnormal plasma cell or b-cell in multiple myeloma emitting paraprotein 3d illustration | Image Credit: © LASZLO - stock.adobe.com

CellCentric Completes $120 Million Series C Funding Round for Multiple Myeloma Treatment Inobrodib

Patrick Lavery
May 21st 2025
Article

Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only multiple myeloma, but other specific cancers as well.


A group of antibiotic pill capsules falling. Healthcare and medical 3D illustration background | Image Credit: © James Thew - stock.adobe.com

Personalised Capsule Machine Unveiled by ACG

Christopher Cole
May 20th 2025
Article

ACG partnered with Art of You to launch the world-first Personalised Capsule Machine, enabling on-demand, customized supplement capsules based on individual health data.

About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.